Elvira O G van Vliet - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Obstetrics and Gynecology|January 13, 2017

Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysisElvira O G van Vliet, Lisa A Askie, Ben W J Mol, et al.

JAMA Pediatrics|May 22, 2013

Perinatal infections and neurodevelopmental outcome in very preterm and very low-birth-weight infants: a meta-analysisElvira O G van Vliet, Jorrit F de Kieviet, Jaap Oosterlaan, et al.

Expert Opinion on Pharmacotherapy|February 19, 2014

Preterm labor: current pharmacotherapy options for tocolysisElvira O G van Vliet, Elisabeth M Boormans, Thomas S de Lange, et al.

American Journal of Obstetrics and Gynecology|April 24, 2012

Placental pathology and long-term neurodevelopment of very preterm infantsElvira O G van Vliet, Jorrit F de Kieviet, J Patrick van der Voorn, et al.

Placenta|November 23, 2016

Placental histology in spontaneous and indicated preterm birth: A case control studyTobias A J Nijman, Elvira O G van Vliet, Manon J N Benders, et al.

Journal of Hypertension|May 25, 2016

Spiral artery remodeling and maternal cardiovascular risk: the spiral artery remodeling (SPAR) studyJan H W Veerbeek, Laura Brouwers, Maria P H Koster, et al.

Nederlands Tijdschrift Voor Geneeskunde|March 12, 2015

[Increased risk of type II diabetes mellitus and cardiovascular disease after gestational diabetes mellitus: a systematic review]Tara-Eileen J P Hopmans, Chantal B van Houten, Annemieke Kasius, et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 28, 2016

Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trialTobias A J Nijman, Elvira O G van Vliet, Christiana A Naaktgeboren, et al.

Lancet (London, England)|March 6, 2016

Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trialElvira O G van Vliet, Tobias A J Nijman, Ewoud Schuit, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Obstetrics and Gynecology|January 13, 2017

Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysisElvira O G van Vliet, Lisa A Askie, Ben W J Mol, et al.

JAMA Pediatrics|May 22, 2013

Perinatal infections and neurodevelopmental outcome in very preterm and very low-birth-weight infants: a meta-analysisElvira O G van Vliet, Jorrit F de Kieviet, Jaap Oosterlaan, et al.

Expert Opinion on Pharmacotherapy|February 19, 2014

Preterm labor: current pharmacotherapy options for tocolysisElvira O G van Vliet, Elisabeth M Boormans, Thomas S de Lange, et al.

American Journal of Obstetrics and Gynecology|April 24, 2012

Placental pathology and long-term neurodevelopment of very preterm infantsElvira O G van Vliet, Jorrit F de Kieviet, J Patrick van der Voorn, et al.

Placenta|November 23, 2016

Placental histology in spontaneous and indicated preterm birth: A case control studyTobias A J Nijman, Elvira O G van Vliet, Manon J N Benders, et al.

Journal of Hypertension|May 25, 2016

Spiral artery remodeling and maternal cardiovascular risk: the spiral artery remodeling (SPAR) studyJan H W Veerbeek, Laura Brouwers, Maria P H Koster, et al.

Nederlands Tijdschrift Voor Geneeskunde|March 12, 2015

[Increased risk of type II diabetes mellitus and cardiovascular disease after gestational diabetes mellitus: a systematic review]Tara-Eileen J P Hopmans, Chantal B van Houten, Annemieke Kasius, et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 28, 2016

Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trialTobias A J Nijman, Elvira O G van Vliet, Christiana A Naaktgeboren, et al.

Lancet (London, England)|March 6, 2016

Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trialElvira O G van Vliet, Tobias A J Nijman, Ewoud Schuit, et al.

Pageof 1